Yale Cancer Center
M

Insights Into Kidney Cancer: Diagnosis, Treatment, and Genetic Components

By Yale Cancer Center FEATURING Michael Hurwitz
By Yale Cancer Center FEATURING Michael Hurwitz
65 views
April 19, 2024
Comments 0
Login to view comments. Click here to Login

Featured Video

19:38
Exelixis

Hypothetical Patient Case: 1L Advanced Renal Cell Carcinoma and Qual…

Feat. R. Alter, A. Rezazadeh

Featured Video

20:14
Exelixis

Hypothetical Patient Case: RAI-R Metastatic Differentiated Thyroid C…

Feat. R. Alter, R. Shameem

Recommended

RENALC-BLADDR-PROSCA 2024

RENALC 2024 - Hybrid Global Forum on GU Oncology

Tue, Nov 26, 2024
16:05

Recent GU Developments and Their Clinical Implications

Insights from 2024 ASCO® GU Annual Meeting

T. Powles, B. Rini

1.5K views
17:50

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

1.9K views
29:25

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

1.2K views
13:37

SIR 2023: Renal Cell Carcinoma Guidelines - What's New in 2023?

SIR 2023 Conference Coverage

N. Kothary

3.0K views
15:58

Best of Bladder Cancer and RCC From ESMO 2023 and GU ASCO 2024

Total Health

M. Reimers

529 views
10:19

ASCO® 2024 Summary: "Current Updates in RCC - Clinical Implications …

2024 ASCO® Annual Meeting Insights Hub

K. Mittal

365 views
07:27

Opus One: Final Results - RFA in Axial Skeleton

Jason Levy

2.0K views
15:28

ASCO® 2024 Summary: "Bladder and RCC Highlights"

2024 ASCO® Annual Meeting Insights Hub

K. Tawagi, N. Reizine

263 views
19:00

New

Treatment (De)Intensification in RCC

International Urology Cancer Summit - IUCS

S. Kumar Pal

155 views
06:41

No Role to Continue ICI Beyond Progression: CONTACT-03 & TiNivo-2 Ph…

Dana-Farber Cancer Institute

B. McGregor

133 views
06:58

ASCO® 2024 Insights: "Systemic Treatments in Favorable and Very Favo…

2024 ASCO® Annual Meeting Insights Hub

M. Zarba

244 views
13:46

Overview of a SoC in 1L mRCC Focusing on the Long-Term Survival Data

David McDermott

247 views
19:41

How I Manage Immune Adverse Events in Solid Tumors

Balazs Halmos

1.9K views
16:14

ESMO 2024 Summary: Important GU Trials - ETER100 (RCC), TACITO (mRCC…

2024 ESMO Annual Meeting Insights Hub

C. Porta

174 views
22:03

RCC Highlights From ASCO® GU 2024

Dana-Farber Cancer Institute

W. Xu, T. Choueiri

331 views
06:49

ASCO® 2024 Insights: "Belzutifan for Advanced Renal Cell Carcinoma"

2024 ASCO® Annual Meeting Insights Hub

E. Jonasch

198 views
06:33

ESMO 2024 Insights: TACITO Trial - Fecal Microbiota Transplantation …

2024 ESMO Annual Meeting Insights Hub

C. Ciccarese

154 views
17:33

1L Treatment Approaches in aRCC: Current Data, Treatment Selection, …

Benjamin Garmezy

251 views
06:55

ESMO 2024 Insights: SC vs. IV Nivolumab in Advanced/Metastatic RCC -…

2024 ESMO Annual Meeting Insights Hub

L. Albiges

115 views
09:54

ASCO® 2024 Insights: "1L Systemic Therapy Following Adjuvant IO in R…

2024 ASCO® Annual Meeting Insights Hub

T. El Zarif

230 views
AUTOPLAY